About SCHOTT Nexterion®
IMPORTANT INFORMATION ABOUT PATENTS
Using arrays based on SCHOTT Nexterion products for dual color analysis on a single array in which at least two different samples are labeled with at least two different labels may require a license under one of the following patents: U.S. patent nos. 5,770,358 or 5,800,992 or 6,225,625 and U.S. patent no. 5,830,645. Manufacturing and use of probe arrays may require a license under the following patents: U.S. patent no. 6,040,138 or 5,445,934 or 5,744,305 and under the following patents owned by Oxford Gene Technology Ltd. („OGT“): European patent no. EP 0,373,203, U.S. patent nos. 5,700,637 and 6,054,270 and Japanese patent nos. 3393528 and 3386391 ("The OGT patents"). Other patents may apply. The purchase of NexterionTM products does not convey any license under any of the OGT patents or any of the other patents referred to. For all applications SCHOTT North America Inc. and SCHOTT Technical Glass Solutions GmbH make no representation or warranty that the practice of its technology and products or any improvement will not infringe or violate any domestic or foreign patent of any third party. Before making or using any oligonucleotide arrays you should contact OGT to discuss a licence. To inquire about licensing under the OGT patents, please contact OGT at email@example.com.